# Immunomodulation With Romiplostim in Young Adults With ITP

> **NCT02760251** · PHASE4 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 15 (actual)

## Conditions studied

- Immune Thrombocytopenia

## Interventions

- **DRUG:** romiplostim

## Key facts

- **NCT ID:** NCT02760251
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-04
- **Primary completion:** 2019-07
- **Final completion:** 2020-03
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2020-05-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02760251

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02760251, "Immunomodulation With Romiplostim in Young Adults With ITP". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT02760251. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*